Singular Genomics Systems, Inc.
NASDAQ:OMIC
23.3 (USD) • At close November 7, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
2023 | 2022 | 2021 | 2020 | 2019 | |
---|---|---|---|---|---|
Operating Activities: | |||||
Net Income
| -94.82 | -90.879 | -98.771 | -27.945 | -12.324 |
Depreciation & Amortization
| 7.223 | 6.032 | 1.133 | 0.639 | 0.35 |
Deferred Income Tax
| 0.782 | 0 | 4.139 | 0.281 | 0 |
Stock Based Compensation
| 11.404 | 13.669 | 9.231 | 1.06 | 0.17 |
Change In Working Capital
| -2.245 | -16.817 | -2.911 | 0.858 | 0.415 |
Accounts Receivables
| 0.348 | -0.913 | 0 | 0 | 0 |
Inventory
| -3.537 | -13.487 | 0 | 0 | 0 |
Accounts Payables
| 0.267 | -1.168 | 1.854 | -0.148 | 0.244 |
Other Working Capital
| 2.922 | -1.249 | -4.765 | 1.006 | 0.171 |
Other Non Cash Items
| 4.009 | 0.901 | 35.478 | 0.234 | -0.01 |
Operating Cash Flow
| -73.647 | -87.094 | -51.701 | -24.873 | -11.399 |
Investing Activities: | |||||
Investments In Property Plant And Equipment
| -0.97 | -6.022 | -4.864 | -1.38 | -0.8 |
Acquisitions Net
| 0 | 33.544 | 125.997 | -25.385 | 30.7 |
Purchases Of Investments
| -183.595 | -174.713 | -195.684 | -6.077 | -42.729 |
Sales Maturities Of Investments
| 198.372 | 141.169 | 69.687 | 31.462 | 12.029 |
Other Investing Activites
| 0 | -33.544 | -125.997 | 25.385 | -30.7 |
Investing Cash Flow
| 13.807 | -39.566 | -130.861 | 24.005 | -31.5 |
Financing Activities: | |||||
Debt Repayment
| 0 | 0 | -10.4 | -7.5 | -2.464 |
Common Stock Issued
| 0.013 | 1.351 | 240.776 | 0.017 | 0.041 |
Common Stock Repurchased
| -0.019 | -0.45 | 3.577 | -0.002 | -0.021 |
Dividends Paid
| 0 | 0 | 0 | 0 | 0 |
Other Financing Activities
| 0.702 | 0.901 | 141.752 | 7.515 | 52.191 |
Financing Cash Flow
| 0.696 | 0.901 | 372.128 | 7.515 | 47.304 |
Other Information: | |||||
Effect Of Forex Changes On Cash
| 0 | 0 | 0 | 0 | 0 |
Net Change In Cash
| -59.144 | -125.759 | 189.566 | 6.647 | 4.405 |
Cash At End Of Period
| 16.833 | 75.977 | 201.736 | 12.17 | 5.523 |